BD bids farewell to its diagnostic, bioscience divisions with company split
The “New BD,” as the company describes it, will continue on as a pure-play medtech with enterprises in medical essentials, interventional devices and connected care.
The “New BD,” as the company describes it, will continue on as a pure-play medtech with enterprises in medical essentials, interventional devices and connected care.
